Dr. Nimgaonkar is an assistant professor and medical director at the Center for Bioengineering Innovation and Design in the Johns Hopkins University Biomedical Engineering department.
He is also an adjunct faculty member at the Johns Hopkins University Carey Business School.
Dr. Nimgaonkar leads translational technology research projects at Johns Hopkins in metabolic diseases and gastroenterology.
He is CellMax Life’s scientific and clinical advisor where he’s led the development of studies for the company’s proprietary blood test that can detect early-stage colorectal cancer and pre-cancer with 84 to 88 percent accuracy.
To submit a gastroenterologist to be featured, please email Rachel Popa at rpopa@beckershealthcare.com.
More articles on gastroenterology:
You’ll never guess what NJ Top Docs named Dr. Joseph Savon
Center for Digestive Medicine offers insight into 3 common GI diseases
Public health coalition urges US Preventive Services Task Force to adopt 45 & over CRC screening guideline
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
